What Is the P/E Ratio? And When Does It Mislead?
The P/E ratio divides stock price by earnings per share — but it breaks for unprofitable companies, cyclical earnings, and cross-sector comparisons. Here is what it actually tells you.
The P/E ratio divides stock price by earnings per share — but it breaks for unprofitable companies, cyclical earnings, and cross-sector comparisons. Here is what it actually tells you.
Sources say Anthropic is fielding preemptive offers for a $40-50B round at $850-900B, backed by Google’s $40B pledge and Amazon’s $13B commitment, with one $5B buyer unable to get a meeting.
Nokia (NOK) climbs 104% YTD after Q1 2026 revenue hits €4.5B and the company returns to profitability — while selling its FWA unit for $200M to focus on 6G.
Beta measures market sensitivity, alpha tracks excess return. Here’s what these numbers mean and four ways CAPM breaks down in practice.
SpaceX’s S-1 targets a $75B raise at a $1.75T valuation — nearly triple Saudi Aramco’s all-time IPO record. What it means for capital markets.
Intel’s stock more than doubled in April 2026 — its best month in 55 years — as Q1 earnings beat expectations and AI server CPU demand rewrites the semiconductor narrative.
Understand the yield curve, what causes inversions, and why they have preceded every U.S. recession since 1955. Includes today’s snapshot.
Kailera Therapeutics’ $625M GLP-1 IPO anchors a Q2 2026 healthcare listing wave, with Hemab Therapeutics, Avalyn Pharma, and peers all jumping 52-89% from their offer prices.
AXT Inc. (AXTI) surged 21% after Q1 2026 revenue rose 39% year-over-year to $26.9M, fueled by AI data-center demand for indium phosphide substrates.
From S-1 filing to first-day pop: how an IPO actually works, covering bookbuilding, the greenshoe stabilization option, and lock-up periods.